Search

GA option bar image

Editorial Feature:

GA Options: Keeping Patients at the Center of GA Therapy

Editorially Independent Content, Supported With Advertising From Astellas and Carl Zeiss Meditec

Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Show Description +

How do John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH, motivate GA patients with good vision—and decide when to start or pause therapy? The panel models patient-centered counseling for asymptomatic patients, explains why many begin monthly dosing before considering every-6-week or every-other-month dosing, and explores how specific imaging modalities track progression, build buy-in, and catch conversion to wet AMD early.

Posted: 9/24/2025

Keywords:

Geographic Atrophy (GA)

•

Patient Experience

•

asymptomatic

•

dosing

•

imaging modalities

•

conversion

•

Wet AMD

•

wet age-related macular degeneration

•

Age-Related Macular Degeneration (AMD)

Up Next

Patient Selection for GA Treatments

Patient Selection for GA Treatments

David RP Almeida, MD, PhD, MBA; Chris Riemann, MD; and Lisa Faia, MD

Real-World GA Case: Case of Bilateral GA with Foveal Involving OD and Extrafoveal Involving OS

Real-World GA Case: Case of Bilateral GA with Foveal Involving OD and Extrafoveal Involving OS

Lisa Faia, MD

Real-World GA Case: GA in the Context of Wet AMD

Real-World GA Case: GA in the Context of Wet AMD

Chris Riemann, MD

Real-World GA Case: Pair of Real-world GA Cases Treated with Avacincaptad Pegol

Real-World GA Case: Pair of Real-world GA Cases Treated with Avacincaptad Pegol

David Almeida, MD, PhD, MBA

Keeping Patients at the Center of GA Therapy: Older Caretaker for Whom Driving Is Paramount

Keeping Patients at the Center of GA Therapy: Older Caretaker for Whom Driving Is Paramount

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: Older, Working Patient Motivated to Continue Treatment

Keeping Patients at the Center of GA Therapy: Older, Working Patient Motivated to Continue Treatment

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: A Young Patient with GA and Good Vision

Keeping Patients at the Center of GA Therapy: A Young Patient with GA and Good Vision

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Back to All Videos

Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

How do John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH, motivate GA patients with good vision—and decide when to start or pause therapy? The panel models patient-centered counseling for asymptomatic patients, explains why many begin monthly dosing before considering every-6-week or every-other-month dosing, and explores how specific imaging modalities track progression, build buy-in, and catch conversion to wet AMD early.

Posted: 9/24/2025

Keywords:

Geographic Atrophy (GA)

•

Patient Experience

•

asymptomatic

•

dosing

•

imaging modalities

•

conversion

•

Wet AMD

•

wet age-related macular degeneration

•

Age-Related Macular Degeneration (AMD)

Please log in to leave a comment.